X0306 4 2016-02-16 0 0001642380 OncoCyte Corp OCX 0001662550 CHAPMAN KAREN B. 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 0 1 0 0 Vice President of Research Option to Purchase Common Stock 3.06 2016-02-16 4 A 0 60000 0.00 A 2026-02-15 Common Stock 60000 60000 D Option to Purchase Common Stock 2.20 2025-01-08 Common Stock 100000 100000 D Option to Purchase Common Stock 1.50 2018-03-31 Common Stock 200000 200000 D Option to Purchase Common Stock 2.20 2025-01-08 Common Stock 125000 125000 I By Spouse Option to Purchase Common Stock 1.34 2020-12-28 Common Stock 250000 250000 I By Spouse One quarter of the options shall vest on February 15, 2017, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant. One quarter of the options vested on January 8, 2016 upon the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant. 1/48th of the number of options vested and became exercisable at the end of each full month of employment after the date of grant on April 1, 2011. One quarter of the options granted to Michael West vested on January 8, 2016, and the balance shall vest in 36 monthly installments from the first anniversary of the date of grant. Dr. West and Dr. Chapman are husband and wife. 1/48th of the number of options granted to Michael West vested and became exercisable at the end of each full month after the date of grant on December 29, 2010. Dr. West and Dr. Chapman are husband and wife. /s/Karen B. Chapman 2016-02-18